The Doubled-Edged Sword of T1-Mapping in Systemic Sclerosis-A Comparison with Infectious Myocarditis Using Cardiovascular Magnetic Resonance.

ECV Lake Louise criteria T2-mapping cardiovascular magnetic resonance myocardial edema myocardial fibrosis parametric scleroderma

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
24 May 2020
Historique:
received: 03 03 2020
revised: 14 05 2020
accepted: 17 05 2020
entrez: 28 5 2020
pubmed: 28 5 2020
medline: 28 5 2020
Statut: epublish

Résumé

T1-mapping is considered a surrogate marker of acute myocardial inflammation. However, in diffuse cutaneous systemic sclerosis (dcSSc) this might be confounded by coexisting myocardial fibrosis. We hypothesized that T1-based indices should not by themselves be considered as indicators of myocardial inflammation in dcSSc patients. A cohort of 59 dcSSc and 34 infectious myocarditis patients was prospectively evaluated using a 1.5-Tesla system for an indication of suspected myocardial inflammation and was compared with 31 healthy controls. Collectively, 33 (97%) and 57 (98%) of myocarditis and dcSSc patients respectively had ≥1 pathologic T2-based index. However, 33 (97%) and 45 (76%) of myocarditis and dcSSc patients respectively had ≥1 pathologic T2-based index. T2-signal ratio was significantly higher in myocarditis patients compared with dcSSc patients (2.5 (0.6) vs. 2.1 (0.4), ~25% of dcSSc patients with suspected myocardial inflammation had no CMR evidence of acute inflammatory processes. T1-based indices should not be used by themselves as surrogates of acute myocardial inflammation in dcSSc patients.

Identifiants

pubmed: 32456347
pii: diagnostics10050335
doi: 10.3390/diagnostics10050335
pmc: PMC7278005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Circ Cardiovasc Imaging. 2017 Feb;10(2):
pubmed: 28213448
Semin Arthritis Rheum. 2014 Feb;43(4):526-35
pubmed: 23932313
J Cardiovasc Magn Reson. 2016 Nov 30;18(1):89
pubmed: 27899132
J Neurosci Methods. 2016 Aug 1;268:1-6
pubmed: 27102045
J Cardiovasc Magn Reson. 2012 Jun 21;14:42
pubmed: 22720998
Inflamm Allergy Drug Targets. 2015;14(1):29-36
pubmed: 26374223
Ann Appl Stat. 2011 Jan 1;5(1):232-253
pubmed: 22081779
Theriogenology. 2010 Jun;73(9):1167-79
pubmed: 20138353
PLoS One. 2015 May 12;10(5):e0126707
pubmed: 25966025
J Cardiovasc Magn Reson. 2017 Oct 9;19(1):75
pubmed: 28992817
Rheumatology (Oxford). 2015 Apr;54(4):647-54
pubmed: 25239881
JACC Cardiovasc Imaging. 2015 Jan;8(1):37-46
pubmed: 25499131
J Am Coll Cardiol. 2016 Apr 19;67(15):1800-1811
pubmed: 27081020
Semin Arthritis Rheum. 2014 Oct;44(2):208-19
pubmed: 24931517
Radiology. 2014 Nov;273(2):383-92
pubmed: 24910904
Circ Cardiovasc Imaging. 2018 Jul;11(7):e007598
pubmed: 30012826
Biostatistics. 2019 Apr 1;20(2):299-314
pubmed: 29420686
Circ Cardiovasc Imaging. 2013 Sep;6(5):833-9
pubmed: 24046380
J Clin Invest. 2007 Mar;117(3):557-67
pubmed: 17332883
J Am Coll Cardiol. 2005 Jun 7;45(11):1815-22
pubmed: 15936612
JACC Cardiovasc Imaging. 2018 Jan;11(1):38-45
pubmed: 28412435
Phys Rep. 2019 May 30;810:1-124
pubmed: 31404441
J Am Coll Cardiol. 2009 Apr 28;53(17):1475-87
pubmed: 19389557
Rheumatology (Oxford). 2019 Nov 25;:
pubmed: 31764972
J Am Coll Cardiol. 2018 Dec 18;72(24):3158-3176
pubmed: 30545455
Biom J. 2019 Jul;61(4):889-901
pubmed: 30742712
JACC Cardiovasc Imaging. 2014 Jul;7(7):667-75
pubmed: 24954462
J Cardiovasc Magn Reson. 2010 Nov 19;12:69
pubmed: 21092095
Cardiology. 2017;138(4):207-217
pubmed: 28813699
Circ Cardiovasc Imaging. 2015 Jun;8(6):
pubmed: 26015267
Eur Heart J Cardiovasc Imaging. 2016 Feb;17(2):154-61
pubmed: 26476398
Ann Rheum Dis. 2009 Dec;68(12):1878-84
pubmed: 19054830
JACC Cardiovasc Imaging. 2013 Oct;6(10):1048-1058
pubmed: 24011774
Int J Cardiol. 2016 Jul 1;214:465-8
pubmed: 27096964
JACC Cardiovasc Imaging. 2016 Jan;9(1):67-81
pubmed: 26762877
Diagn Interv Imaging. 2015 Sep;96(9):885-90
pubmed: 25697831
Arthritis Rheum. 2007 Nov;56(11):3827-36
pubmed: 17968945
Ann Rheum Dis. 2007 Jul;66(7):940-4
pubmed: 17329309

Auteurs

George Markousis-Mavrogenis (G)

Cardiology Department, Onassis Cardiac Surgery Center, 17674 Athens, Greece.

Loukia Koutsogeorgopoulou (L)

Pathophysiology Dpt., Laikon Hospital, 11527 Athens, Greece.

Gikas Katsifis (G)

Rheumatology Unit, Navy Hospital, 11521 Athens, Greece.

Theodoros Dimitroulas (T)

Internal Medicine Dpt., Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.

Genovefa Kolovou (G)

Cardiology Department, Onassis Cardiac Surgery Center, 17674 Athens, Greece.

George D Kitas (GD)

Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester M13 9PL, UK.

Petros P Sfikakis (PP)

First Department of Propaedeutic and Internal Medicine, Laikon Hospital, Athens University Medical School, 11527 Athens, Greece.

Sophie I Mavrogeni (SI)

Cardiology Department, Onassis Cardiac Surgery Center, 17674 Athens, Greece.
National and Kapodistrian University of Athens, 15772 Athens, Greece.

Classifications MeSH